CRBP TRADING AT A DEAL
This company sold off because they said they were cutting 54% of their workers to help with cash flow into 2022 during the coronavirus pandemic. The market has clearly priced that in, and I honestly think it's long term bullish! Less employees: less people to pay out! CRBP has a lot of potential upside (more than likely not anytime soon), however, they have the 1st potential systematic sclerosis therapy that is looking to receive FDA approval some time around 2021 . Estimated revenue projections for the therapy, which would meet a need created by 320,000 patients worldwide if/when approved, are at 8 billion dollars. With only phase 2 data CRBP was able to get a deal from japan to close a deal for 27M (about 37,000 patients there). CRBP says they are trying to get the EU, and the rest of the globe for that matter, on board; If the EU was to grant a deal similar to Japans deal (made in 2018 btw), they could receive 233 million for that deal. All of this data is from a seeking alpha article; at 7 dollars they said the company has 2x upside from there. In all honesty I suspect to see a buyout in about 6 months or so... just a feeling; this stock is giving me an 'AIMT' vibe.
GL!
GL!
Note
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.